TCL Archive The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff. October 21, 2005
TCL Archive In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule November 5, 1976
TCL Archive NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions. December 12, 2003
